Trials / Withdrawn
WithdrawnNCT01574872
Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis
Double-blind, Randomized, Placebo Controlled Study Evaluating the Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Tecno Sun SRL · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of Aerosal® compared to placebo in the prognosis of inverse psoriasis or sebopsoriasis present for at least one year
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Halotherapy | The treatment consist of 15 session of micronized iodized salt (sodium chloride) skin exposure in a chamber that reproduces the environmental characteristics of a natural salt cave. Each daily session last 30 minutes. |
| DEVICE | Placebo | The treatment consist of 15 sessions in a chamber that emulates the environmental characteristics of a natural salt cave but with no salt emanation. Each daily session last 30 minutes. |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-01-01
- Completion
- 2013-04-01
- First posted
- 2012-04-10
- Last updated
- 2014-11-18
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01574872. Inclusion in this directory is not an endorsement.